This is the latest Respiratory Drug Delivery conference in a series that has run continuously since 1988 and garnered a sustained reputation for excellent content covering all aspects of drug delivery to the lungs and nose.
Author profile
Philip Canner
Head of Drug Delivery
With over twenty years’ experience in medical device leadership, engineering, and management consultancy, Philip has led the development of an extensive range of medical technologies, with a particular focus on drug delivery.



